Attorneys for Purdue Pharma and parties favoring its $4.3 billion bankruptcy settlement on Friday urged the U.S. Court of Appeals for the Second Circuit to reverse the district court's ruling vacating the deal, arguing that the liability release for the Sackler family were appropriate and well-tailored.